Aishwarya Gokuldass

Title: Aishwarya Gokuldass: Innovator in Cancer Immunotherapy

Introduction

Aishwarya Gokuldass is a prominent inventor based in Chennai, India. She has made significant contributions to the field of cancer immunotherapy, particularly through her innovative work on engineered artificial antigen presenting cells. With two patents to her name, Aishwarya is at the forefront of developing new methods for cancer treatment.

Latest Patents

Aishwarya's latest patents focus on engineered artificial antigen presenting cells (aAPCs) for tumor infiltrating lymphocyte (TIL) expansion. These patents describe compositions and methods involving isolated aAPCs that comprise a myeloid cell transduced with viral vectors. The myeloid cells express essential proteins such as HLA-AB/C, ICOS-L, and CD58. The viral vectors include nucleic acids encoding CD86 and 4-1BBL and/or OX40L, which enable the myeloid cells to express these proteins. The methods outlined in her patents also detail how to expand TILs using aAPCs and how to treat cancers with these expanded TILs.

Career Highlights

Aishwarya Gokuldass is currently employed at Iovance Biotherapeutics, Inc., where she continues her research in cancer immunotherapy. Her work is pivotal in advancing the understanding and treatment of various cancers through innovative cellular therapies.

Collaborations

Some of Aishwarya's notable coworkers include Anand Veerapathran and Brian Rabinovich. Their collaborative efforts contribute to the ongoing research and development in the field of immunotherapy.

Conclusion

Aishwarya Gokuldass is a trailblazer in the realm of cancer treatment, with her innovative patents paving the way for new therapeutic approaches. Her contributions are vital to the future of cancer immunotherapy and the development of effective treatments.